Progressive vaccinia treated with ribavirin and vaccinia immune globulin

被引：39

作者：

Kesson, AM

Ferguson, JK

Rawlinson, WD

Cunningham, AL

机构：

[1] HUNTER AREA HLTH SERV,DEPT MICROBIOL,NEWCASTLE,NSW,AUSTRALIA

[2] WESTMEAD HOSP,INST CLIN PATHOL & MED RES,DEPT VIROL,WESTMEAD,NSW 2145,AUSTRALIA

来源：

CLINICAL INFECTIOUS DISEASES | 1997年 / 25卷 / 04期

关键词：

D O I：

10.1086/515534

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A 67-year-old man with metastatic melanoma and chronic lymphocytic leukemia was inadvertently given a vaccinia melanoma oncolysate vaccination, He developed progressive vaccinia at the site of inoculation, The lesion started to heal only when he was treated with ribavirin, Vaccinia immune globulin was administered and appeared to help control the initial lesion and limit the development of satellite lesions.

引用

页码：911 / 914

页数：4

共 16 条

[1] CLINICAL EXPERIENCE WITH ANTIVIRAL DRUG MARBORAN (1-METHYLISATIN 3-THIOSEMICARBAZONE) [J].